Concepedia

M. Arning

MA

Statistics

Publications

38

Citations

8.2K

H-Index

28

Active since

1989

Affiliations

Heinrich Heine University Düsseldorf(Current)

Charité - Universitätsmedizin Berlin

Cornell University

GlaxoSmithKline (United States)

GlaxoSmithKline (United Kingdom)

M. Arning is an author at Heinrich Heine University Düsseldorf specializing in medicine, chemotherapy, and pharmacology.

Publications per year

1989–2013

38

Publications

38

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Hans von der Maase, Lisa Sengeløv, J.T. Roberts et al. · Journal of Clinical Oncology · 2005 · 1.9K citations

, , +6

Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

Helmut Oettle, P. Neuhaus, Andreas Hochhaus et al. · JAMA · 2013 · 1.8K citations

, , +16

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic Purpura

James B. Bussel, Gregory Cheng, Mansoor N. Saleh et al. · New England Journal of Medicine · 2007 · 805 citations · Full text

, , +13

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

Gregory Cheng, Mansoor N. Saleh, Claus Werenberg Marcher et al. · The Lancet · 2010 · 582 citations · Full text

, , +7

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

James B. Bussel, Drew Provan, Tahir Shamsi et al. · The Lancet · 2009 · 539 citations

, , +10

1–5 of 38